Experimental Monoclonal Antibodies Offer A Possible New Treatment Approach For EBV

EBV, or Epstein-Barr virus, is a form of viral infection. It is one of the most commonly found viral infections in humans and is most notably associated with mononucleosis, otherwise known as mono. It’s estimated that as much as 90% of the worldwide population has this virus in their body. However, not everyone experiences symptoms, which is why it is so spreadable. Once a person contracts EBV, it remains in their body for life, but goes dormant. That means that it can call the human body home without causing any symptoms or notable health concerns.

That said, an EBV virus can lead to the development of certain diseases, some of which can be serious and even life-threatening. The most significant health issues arising from EBV include cancer, Hodgkin’s lymphoma, and autoimmune disease such as multiple sclerosis (MS). In people with weakened immune systems, the likelihood of these complications is higher than in those with healthy and strong immunity.

Currently, no treatments are available for an EBV infection beyond managing symptoms at home. However, this may change due to a recent discovery involving monoclonal antibodies.

Continue reading “Experimental Monoclonal Antibodies Offer A Possible New Treatment Approach For EBV”